• T0070907: Advancing Translational Control of PPARγ Signaling

  2026-05-09

  This thought-leadership article examines how the selective PPARγ antagonist T0070907 empowers translational researchers to dissect complex PPARγ signaling in metabolic and cancer biology. Bridging mechanistic insight, recent advances in senescence-driven inflammation, and practical workflow guidance, the piece offers strategic direction for leveraging T0070907 in advanced cell signaling research. Distinct from typical reagent pages, it synthesizes competitive landscape data, protocol strategies, and translational relevance, while contextualizing findings from recent studies on the RXRα/PPARγ/NEDD4 axis in atherosclerosis.

• Quercetin Enhances Angiogenesis and BSCB Integrity After SCI

  2026-05-08

  Liu et al. demonstrate that quercetin promotes vascular regeneration and preserves blood-spinal cord barrier (BSCB) structure following spinal cord injury (SCI) by activating the PI3K/Akt pathway. These insights highlight a potential therapeutic strategy targeting endothelial survival and barrier protection for improved neurological recovery in SCI models.

• RBMS1 Loss Enhances PD-L1 Blockade in Triple-Negative Breast

  2026-05-08

  This study identifies RBMS1 as a crucial regulator of PD-L1 stability in triple-negative breast cancer (TNBC), demonstrating that RBMS1 depletion impairs PD-L1 glycosylation and promotes its degradation. These findings highlight a new strategy to improve immunotherapy efficacy in immune-cold TNBC by targeting RNA-binding proteins that influence immune checkpoint pathways.

• APOL1 Evolution, Splice Isoforms, and APOL3: Mechanisms of C

  2026-05-07

  This study dissects the molecular evolution of APOL1, its splice isoform diversity, and native interaction with APOL3, illuminating how these factors converge to influence cellular injury mechanisms underlying kidney disease. The integration of population genetics, isoform-specific functional assays, and protein–protein interaction analyses advances our mechanistic understanding of APOL1's dual roles in innate immunity and renal cytotoxicity.

• Dacarbazine in Translational Oncology: A Mechanistic Roadmap

  2026-05-07

  Explore the multifaceted role of dacarbazine as an antineoplastic chemotherapy drug, emphasizing its mechanistic DNA alkylation, translational research strategies, and real-world clinical integration. This thought-leadership article provides new guidance for researchers aiming to optimize dacarbazine’s use in malignant melanoma, Hodgkin lymphoma, and sarcoma, while highlighting experimental and workflow best practices.

• Selective IMPDH2 Inhibition by Berberrubine in Colorectal Ca

  2026-05-06

  This study identifies berberrubine as a potent and selective inhibitor of IMPDH2, demonstrating its ability to suppress colorectal cancer cell growth in vitro and in vivo. The findings expand the therapeutic landscape for anti-colorectal cancer agents by targeting nucleotide biosynthesis with high selectivity, reducing potential side effects.

• Pentoxifylline Modulates T Cell Responses in Leishmania and

  2026-05-06

  This study demonstrates that pentoxifylline, a phosphodiesterase inhibitor, can attenuate pathological immune responses in both Leishmania and HTLV-I infections by downregulating pro-inflammatory cytokine production. The findings have important implications for the immunotherapeutic management of chronic infectious diseases characterized by tissue-damaging inflammation.

• Caspase-3 and ERO1α Drive Mitochondrial ROS in Trichothecene

  2026-05-05

  This study uncovers a dual mechanism of trichothecene-induced hepatotoxicity: caspase-3-mediated cleavage of mitochondrial NDUFS1 amplifies ROS generation, while ER-localized ERO1α serves as an additional, non-mitochondrial ROS source. The findings provide mechanistic insight into how trichothecenes disrupt redox balance, offering new avenues for targeted intervention in mycotoxin-induced liver damage.

• Grazoprevir Hydrate: Mechanistic Precision in HCV Research &

  2026-05-05

  Explore how Grazoprevir hydrate advances hepatitis C virus replication inhibition through mechanistic precision and robust clinical performance. This article offers a unique, in-depth analysis for both research and translational applications.

• Metabolic Enhancement of Ferroptosis and Cuproptosis in Tumo

  2026-05-04

  This article examines a recent metabolic intervention strategy that synchronously sensitizes tumor cells to ferroptosis and cuproptosis, thereby enhancing anti-tumor immunity. Through glycolysis and NAD+ metabolism inhibition, the study demonstrates improved efficacy of copper-based nanotherapeutics in cancer models, offering new avenues for regulated cell death-based oncology research.

• Serotonin Inhibits HRP-Mediated Proximity Labeling in Neuron

  2026-05-04

  This study reveals that serotonin specifically inhibits horseradish peroxidase (HRP)-mediated proximity-dependent biotinylation, a strategy widely used for mapping cell surface proteomes. The findings underscore the need to account for neurotransmitter interference during cell surface protein labeling, with practical strategies demonstrated to restore signal amplification accuracy.

• Coronavirus Macrodomains, PARP Inhibition, and Host Antivira

  2026-05-03

  Grunewald et al. (2019) demonstrate that the coronavirus macrodomain is essential to counter poly (ADP-ribose) polymerase (PARP)-mediated antiviral defenses, notably those involving PARP12 and PARP14. Their findings illuminate a new axis in virus-host interaction, with implications for targeting ADP-ribosylation pathways in antiviral research.

• LG 101506 RXR Modulation: Transforming Immuno-Metabolic Rese

  2026-05-02

  This thought-leadership article dissects the mechanistic significance and translational promise of LG 101506, a high-purity RXR modulator from APExBIO. Framed by emerging insights in immune-cold tumor biology and nuclear receptor signaling, it guides researchers in optimizing experimental design, bridging immunometabolism, and accelerating therapeutic innovation. Evidence from recent literature and benchmark workflows underscores LG 101506's unique value for those seeking to unlock the full potential of RXR signaling pathway research.

• EGCG Nanoparticles Amplify FLASH-RT Efficacy via DNA Damage

  2026-05-01

  This study demonstrates that functionalized EGCG nanoparticles (BENPs) significantly enhance the antitumor effects of ultra-high dose rate radiotherapy (FLASH-RT) by promoting DNA double-strand breaks and stimulating antitumor immunity. The findings provide mechanistic insights and inform future strategies to optimize cancer radiotherapy protocols.

• Frizzled5 as a Cholesterol Sensor Linking Lipid Metabolism t

  2026-05-01

  This study uncovers a unique mechanism where Frizzled5 (Fzd5) directly binds cholesterol, enabling its maturation and trafficking, which is essential for Wnt/β-catenin signaling and pancreatic cancer growth. The findings establish a mechanistic bridge between cholesterol metabolism and oncogenic Wnt signaling, suggesting new therapeutic targets for Wnt-driven cancers.

15785 records 1/1053 page Next 12345 下5页 Last page